Skip to main content

BRCA1 and BRCA2 Genetic Testing: 2 Medicare contractor policies compared

2 Local Coverage Determinations in the current Medicare Coverage Database export carry the title "BRCA1 and BRCA2 Genetic Testing", between them covering 15 states and territories. 2 of them have a billing and coding article with a diagnosis list, ranging from 71 to 93 covered ICD-10-CM codes. The table below is the fastest way to see which version governs a given state and how far the versions have drifted.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Policies with this title
2
States covered
15
Versions with a coded article
2
Revision dates
2020-12-10 to 2020-12-10

Every version by contractor

Open a version for its full policy text, contracts, codes and related NCDs. Covered codes are the count of ICD-10-CM codes in the version's billing and coding article; a dash means the export attaches no coded article.

Local Coverage Determinations titled "BRCA1 and BRCA2 Genetic Testing"
LCDContractorStatesRevisedCovered codesPolicy words
L36499First Coast Service Options, Inc.FL PR VI2020-12-10933,244
L36715Novitas Solutions, Inc.AR CO DC DE LA MD MS NJ NM OK PA TX2020-12-10712,664

Which diagnoses each contractor covers

Across the 2 versions with a coded billing and coding article, 95 ICD-10-CM codes are covered by at least one contractor: 69 by every version and 26 (27%) by only some of them. L36499 (First Coast Service Options, Inc.) covers the most codes no other version lists (24). L36715 (Novitas Solutions, Inc.) leaves out the most codes that every other version covers (24), the version where a diagnosis accepted elsewhere is most often absent. The comparison is mechanical: it counts codes on the lists and does not weigh the policy text, frequency limits or documentation rules, which can matter as much as the list.

Unique codes appear on that version's covered list only; missing codes are covered by every other version but not by this one. Lists are the union of the coded billing and coding articles linked to each LCD (MCD release 2026-11-12).

Covered ICD-10-CM codes per version of BRCA1 and BRCA2 Genetic Testing
LCDContractorArticlesCoveredOnly hereMissing
L36499First Coast Service Options, Inc.A5744993242
L36715Novitas Solutions, Inc.A5654271224

Where the lists part

Three-character ICD-10-CM categories ranked by how many of their codes are covered by some versions and not others; a category near the top is where checking the local list matters most.

ICD-10-CM categories with the most codes only some versions of BRCA1 and BRCA2 Genetic Testing cover
CategoryCategory title (FY2027)Codes that differ
C50Malignant neoplasm of breast18
D05Carcinoma in situ of breast4
Z17Estrogen, and other hormones and factors receptor status2
C56Malignant neoplasm of ovary1
C57Malignant neoplasm of other and unspecified female genital organs1

Code-by-contractor sample

All 26 codes covered by some versions and not others, codes that most versions cover first and no more than three per category in the first pass. Y means the version's covered list includes the code.

26 of the 26 ICD-10-CM codes that only some versions of BRCA1 and BRCA2 Genetic Testing cover
ICD-10-CMDescription (FY2027)L36499L36715
C50.019Malignant neoplasm of nipple and areola, unspecified female breastY—
C50.029Malignant neoplasm of nipple and areola, unspecified male breastY—
C50.119Malignant neoplasm of central portion of unspecified female breastY—
C50.129Malignant neoplasm of central portion of unspecified male breastY—
C50.219Malignant neoplasm of upper-inner quadrant of unspecified female breastY—
C50.229Malignant neoplasm of upper-inner quadrant of unspecified male breastY—
C50.319Malignant neoplasm of lower-inner quadrant of unspecified female breastY—
C50.329Malignant neoplasm of lower-inner quadrant of unspecified male breastY—
C50.419Malignant neoplasm of upper-outer quadrant of unspecified female breastY—
C50.429Malignant neoplasm of upper-outer quadrant of unspecified male breastY—
C50.519Malignant neoplasm of lower-outer quadrant of unspecified female breastY—
C50.529Malignant neoplasm of lower-outer quadrant of unspecified male breastY—
C50.619Malignant neoplasm of axillary tail of unspecified female breastY—
C50.629Malignant neoplasm of axillary tail of unspecified male breastY—
C50.819Malignant neoplasm of overlapping sites of unspecified female breastY—
C50.829Malignant neoplasm of overlapping sites of unspecified male breastY—
C50.919Malignant neoplasm of unspecified site of unspecified female breastY—
C50.929Malignant neoplasm of unspecified site of unspecified male breastY—
C56.9Malignant neoplasm of unspecified ovaryY—
C57.00Malignant neoplasm of unspecified fallopian tubeY—
D05.00Lobular carcinoma in situ of unspecified breastY—
D05.10Intraductal carcinoma in situ of unspecified breastY—
D05.80Other specified type of carcinoma in situ of unspecified breastY—
D05.90Unspecified type of carcinoma in situ of unspecified breastY—
Z17.0Estrogen receptor positive status [ER+]—Y
Z17.1Estrogen receptor negative status [ER-]—Y

Download every covered code with a column per LCD (CSV). The LCD coverage variation report ranks every multi-contractor title by how far its lists diverge.

How to use the comparison

Start from the state where the service is furnished and open that contractor's version; its billing and coding article carries the diagnosis codes the claims system will test. For a group that bills in several jurisdictions, the version with the smallest covered list is the safe common denominator for pre-service review, and the version with the largest list shows what documentation can support an appeal elsewhere. The L36715 version is the one most searched for this title; the LCD lookup guide explains how jurisdictions are assigned, and the LCD hub lists every topic that more than one contractor has written.

For teams evaluating QuickIntell software

Where QuickIntell fits across jurisdictions

For teams working across MAC jurisdictions, evaluate how requirements, source policies and documentation review should be organized for each case. Confirm jurisdiction-specific scope and supported actions during a QuickAuth evaluation; compare claim and denial follow-up separately in QuickRCM.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

Why are there 2 LCDs called "BRCA1 and BRCA2 Genetic Testing"?

Each Medicare Administrative Contractor writes its own Local Coverage Determination for its jurisdiction. 2 contractors publish a policy with this title covering 15 states; they often start from one contractor's text and then revise separately, so dates, criteria and diagnosis lists differ by jurisdiction.

Which "BRCA1 and BRCA2 Genetic Testing" LCD applies to my claim?

The one written by the contractor that processes the claim: the A/B MAC for the state where the service is furnished, or the DME MAC region for equipment. The table lists each policy's states; open the policy for that jurisdiction and its billing and coding article.

How different are the diagnosis lists?

Across the 2 versions with a coded billing and coding article, 95 ICD-10-CM codes are covered by at least one contractor: 69 by every version and 26 (27%) by only some of them. A diagnosis accepted under one contractor's version can deny under another's, so a group that bills in several jurisdictions checks the list of the contractor that processes each claim.

When were these policies last revised?

Revision effective dates run from 2020-12-10 to 2020-12-10. A claim is judged against the version in force on the date of service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.